Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Idaho for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Idaho only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Idaho (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Dustin Dinning (NPI 1578774022)

Field	Value
Entity Type	Individual
Organization	Dustin Dinning
Address	3815 N Schreiber Way Ste 101
City	Coeur D Alene
State	ID
ZIP	83815
Taxonomy	Rheumatology Physician
NPI Enumerated	May 25, 2007

Payer Source	Total Paid
Medicare	$1.1M
Medicaid	$0

Key Findings

This provider is a specialist in infusion-based rheumatology care: the top revenue-driving codes are biologic drug administrations (J0129, J1602, J3262) and biosimilar infusions (Q5104, Q5119), with many additional IV administration and chemotherapy-adjacent codes (96413, 96365, 96367) present. The mix indicates the practice primarily delivers infused biologic therapies in-office under physician supervision rather than pill-based chronic management.

Medicare revenue is concentrated in a small number of high-cost drugs: the precomputed top three Medicare codes account for 61.0% of this provider's total Medicare revenue, demonstrating heavy dependence on a few biologic agents for most Medicare billings. That concentration suggests the practice’s financial profile is closely tied to utilization and reimbursement of specific injectable biologics.

Scale and payer mix are skewed to Medicare only: lifetime Medicare revenue is reported at $1.1M while there is no Medicaid billing on file, so the provider operates effectively as a single-payer (Medicare) billing entity in the available data. This absence of Medicaid activity means analyses of Medicaid competitiveness or in-state payer behavior cannot be performed for this provider.

Competitive standing on major biologics is mixed: the provider’s J0129 revenue ($336.6K, 31.3% of Medicare revenue) ranks at the 60th percentile nationally (described as typical, unremarkable volume), while Q5104 revenue ($133.1K, 12.4% of Medicare revenue) ranks at the 90th percentile nationally (typical volume but comparatively high relative placement). These rankings indicate the provider is a modest-to-strong regional participant for certain infliximab biosimilars but not an outlier for abatacept.

High-volume office E/M coding is notable for established visits: 99214 appears as a material non-drug revenue source with 730 claims and $61.3K (5.7% of Medicare revenue), ranking in the 95th percentile nationally and marked as notably above typical volume. This suggests the practice maintains substantial longitudinal outpatient management alongside infusion services, supporting both clinic visit intensity and infusion throughput.

Operational throughput is reflected by numerous administration and infusion add-on codes (96365, 96367, 96415, 96375) with typical national percentile placements (mostly between the 68th and 82nd percentiles). These patterns indicate steady infusion session volume and the use of add-on billing for prolonged or multiple infusions, consistent with a practice organized to deliver repeated in-office biologic administrations.

Tenure in the Medicare program is long-standing: the NPI was enumerated on 2007-05-25 (~19 years ago), indicating nearly two decades of enrollment which supports the development of an established referral and infusion-based practice rather than a recent entrant. This longevity aligns with the mix of mature biologic and infusion services shown in billing.

There are no Medicaid claims to contextualize in-state competitive positioning: because the provider has no Medicaid billing on file, any assessment of market share or competitive rank within Idaho Medicaid is not possible. Analysts should treat this profile as Medicare-centric when modeling payer risk or network participation for this entity.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

27 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	9,900	$30	$336.6K
J1602	Injection, golimumab, 1 mg, for intravenous use	18,100	$10	$181K
J3262	Injection, tocilizumab, 1 mg	27,790	$10	$138.9K
Q5104	Injection, infliximab-abda, biosimilar, (renflexis), 10 mg	5,120	$30	$133.1K
Q5119	Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg	4,040	$20	$80.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	730	$80	$61.3K
J0897	Injection, denosumab, 1 mg	2,580	$20	$49K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	360	$90	$33.8K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	180	$130	$22.8K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	160	$50	$7.3K

Showing 1–10 of 27

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Idaho Distribution

Dustin Dinning — 4 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Idaho

Full comparison — all codes billed, vs. state median

27 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	5	10	9,950	$30	$369.8K
J3262	3	10	27,790	$1	$340.8K
J1602	4	10	15,030	$10	$266.6K
J3490	4	10	230	$880	$174.8K
Q5104	1	10	5,120	$30	$133.7K
J0897	13	30	2,580	$20	$76.2K
Q5119	1	10	3,200	$20	$71.3K
96413	6	20	250	$90	$26K
99214	46	2,690	90	$70	$10.4K
96365	7	20	80	$40	$7.4K

Showing 1–10 of 27

Related Providers

Other providers that share a Tax Identification Number (TIN) with Dustin Dinning, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Kootenai Health, Inc.	ID	General Acute Care Hospital	$0	$7M
Kootenai Health, Inc.	ID	Psychiatry Physician	$0	$6.7M
Kootenai Urgent Care LLC	ID	Family Medicine Physician	$0	$3.8M
David Bartels	ID	Hematology & Oncology Physician	$3.5M	$0
Kootenai Health, Inc.	ID	Emergency Medicine Physician	$0	$2.6M
Danko Martincic	ID	Hematology & Oncology Physician	$2.6M	$0
Golden Buckland	ID	Ophthalmology Physician	$1.2M	$0
Howard Kenney	ID	Rheumatology Physician	$1.2M	$0
Alison Granier	ID	Ophthalmology Physician	$842.5K	$0
Jonathan Sharrett	ID	Radiation Oncology Physician	$727.8K	$0

Nearby Providers

Other providers in the same ZIP code as Dustin Dinning, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Syringa Family Partnership, LLC	ID	Early Intervention Provider Agency	$0	$10.4M
North Star Child Development Center	ID	Clinic/Center	$0	$9.4M
Tesh, Inc.	ID	Developmentally Disabled Services Day Training Agency	$0	$3.5M
Jump Start Pediatric Therapy, LLC	ID	Physical Therapy Clinic/Center	$0	$3.3M
Synergy Healthcare For Kids Inc.	ID	Rehabilitation Clinic/Center	$0	$1.8M
George J Loftus Iii, Dds, LLC	ID	General Practice Dentistry	$0	$1.8M
A Compassionate In-home Care LLC	ID	In Home Supportive Care Agency	$0	$1.6M
Rathdrum Clinic, Inc.	ID	Addiction Medicine (Family Medicine) Physician	$0	$1.1M
Emeritus Corporation	ID	Assisted Living Facility	$0	$739.9K
Empowered Through Play LLC	ID	Mental Health Counselor	$0	$641K

Dustin Dinning — Billing Profile & Reimbursement Data

Sign up for Dustin Dinning — Billing Profile & Reimbursement Data policy alerts

Dustin Dinning — Billing Profile & Reimbursement Data

Sign up for Dustin Dinning — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References